Weil, Fenwick Steer Sanofi's Up To $1.2B Deal For Amunix
Sanofi SA, guided by Weil Gotshal & Manges, said Tuesday it plans to buy immuno-oncology company Amunix Pharmaceuticals, led by Fenwick & West, for $1.2 billion including contingency payments to further...To view the full article, register now.
Already a subscriber? Click here to view full article